Taking action to ease suffering: advancing cancer pain control as a health care priority.

Autor: Brawley OW, Smith DE, Kirch RA

Publikováno v: CA: A Cancer Journal for Clinicians; Sep/Oct2009, Vol. 59 Issue 5, p285-289, 5p

Physician Workforce Disparities and Patient Care: A Narrative Review.

Autor: Silver JK; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Network, Massachusetts General Hospital, and Brigham and Women's Hospital, Boston, Massachusetts., Bean AC; Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, New York., Slocum C; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Network, and Massachusetts General Hospital, Boston, Massachusetts., Poorman JA; Department of Physical Medicine and Rehabilitation, Harvard Medical School and Spaulding Rehabilitation Network, Boston, Massachusetts., Tenforde A; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Brigham and Women's Hospital, and Spaulding Rehabilitation Network, Boston, Massachusetts., Blauwet CA; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Brigham and Women's Hospital, and Spaulding Rehabilitation Network, Boston, Massachusetts., Kirch RA; National Patient Advocate Foundation, Washington, District of Columbia., Parekh R; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.; American Psychiatric Association, Washington, District of Columbia., Amonoo HL; Department of Psychiatry, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts., Zafonte R; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Network, Massachusetts General Hospital, and Brigham and Women's Hospital, Boston, Massachusetts., Osterbur D; Countway Library of Medicine, Harvard Medical School, Boston, Massachusetts.

Publikováno v: Health equity [Health Equity] 2019 Jul 01; Vol. 3 (1), pp. 360-377. Date of Electronic Publication: 2019 Jul 01 (Print Publication: 2019).

Enhancing quality of life as a goal for anticancer therapeutics.

Autor: Pettit SD; Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit@hesiglobal.orgSteven E. Lipshultz is Pediatrician-in-Chief of Children's Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children's Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA., Lipshultz SE; Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit@hesiglobal.orgSteven E. Lipshultz is Pediatrician-in-Chief of Children's Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children's Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA., Cleeland CS; Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit@hesiglobal.orgSteven E. Lipshultz is Pediatrician-in-Chief of Children's Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children's Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA., Roberts S; Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit@hesiglobal.orgSteven E. Lipshultz is Pediatrician-in-Chief of Children's Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children's Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA., Davis M; Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit@hesiglobal.orgSteven E. Lipshultz is Pediatrician-in-Chief of Children's Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children's Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA., Berridge BR; Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit@hesiglobal.orgSteven E. Lipshultz is Pediatrician-in-Chief of Children's Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children's Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA., Kirch RA; Syril D. Pettit is the Executive Director of the ILSI, Health and Environmental Sciences Institute (HESI), Washington, DC 20005, USA. Email: spettit@hesiglobal.orgSteven E. Lipshultz is Pediatrician-in-Chief of Children's Hospital of Michigan; Chair of Pediatrics, Wayne State University School of Medicine; President of University Pediatricians; and Interim Director of Children's Research Center of Michigan, Detroit, MI 48201, USA; and Editor-in-Chief, Cardio-Oncology.Charles S. Cleeland is McCullough Professor of Cancer Research, Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.Samantha Roberts is Director of Scientific Affairs, Friends of Cancer Research, Washington, DC 20036, USA.Myrtle Davis is Chief, Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute, Bethesda, MD 20892, USA.Brian R. Berridge is Senior GSK Fellow and Head of Worldwide Animal Research Strategy, GlaxoSmithKline, King of Prussia, PA 19406, USA.Rebecca A. Kirch is Executive Vice President, Healthcare Quality and Value, National Patient Advocate Foundation, Washington, DC 20005, USA.

Publikováno v: Science translational medicine [Sci Transl Med] 2016 Jun 22; Vol. 8 (344), pp. 344ed9.

Response to editorial by Richard Crevenna, MD, regarding "cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services" by Silver et al.

Autor: Silver JK; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Hospital, 300 First Avenue, Charlestown, MA, 02129, USA. julie_silver@hms.harvard.edu., Smith SR; Department of Physical Medicine & Rehabilitation, University of Michigan, 325 E Eisenhower Pkwy, Ste 100, Ann Arbor, MI, 48108, USA. srsz@med.umich.edu., Wisotzky EM; MedStar National Rehabilitation Network, 102 Irving St, NW, Washington, DC, 20010, USA. eric.m.wisotzky@medstar.net., Raj VS; Department of Physical Medicine and Rehabilitation, Carolinas Rehabilitation, 1100 Blythe Boulevard, Charlotte, NC, 28203, USA. vishwa.raj@carolinashealthcare.org., Fu JB; Department of Palliative, Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 1414, Houston, TX, 77030, USA. jfu@mdanderson.org., Kirch RA; American Cancer Society, 555 11th Street NW, Suite 300, Washington, DC, 20004, USA. rkirch@cancer.org.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2015 Dec; Vol. 23 (12), pp. 3409-10. Date of Electronic Publication: 2015 Aug 23.

Early specialty palliative care--translating data in oncology into practice.

Autor: Parikh RB; From Harvard Medical School (R.B.P.) and Massachusetts General Hospital (J.S.T.) - both in Boston; the American Cancer Society, Washington, DC (R.A.K.); and Johns Hopkins University, Baltimore (T.J.S.)., Kirch RA, Smith TJ, Temel JS

Publikováno v: The New England journal of medicine [N Engl J Med] 2013 Dec 12; Vol. 369 (24), pp. 2347-51.